DxScript

DxScript is a cloud-based ePrescribing platform designed to streamline the electronic prescription process for healthcare providers across the United States. Built with compliance, security, and efficiency as core priorities, DxScript supports both stand-alone and integrated operation, enabling flexible adoption for clinics, private practices, hospitals, and telehealth providers. The software is certified for Electronic Prescribing of Controlled Substances (EPCS) in all 50 states, positioning it as a robust solution for practices that require regulatory adherence and a seamless workflow for controlled and non-controlled medications. DxScript is a HIPAA-, SOC 1-, and SOC 2-compliant platform, safeguarding patient information by leveraging industry-standard security protocols. The application is accessible through web browsers—including Chrome, Edge, and Safari—and supports mobile devices such as iPhone, iPad, and Android, allowing providers to manage prescriptions efficiently wherever they are. The use of Two Factor Authentication (2FA) for controlled substance prescriptions further enhances system security. Encryption at rest is employed for Protected Health Information (PHI), offering an additional layer of data protection for healthcare organizations. The software connects with more than 100 EMR, EHR, and practice management (PM) systems via standard APIs, such as HL7, FHIR, CDA, and SOAP services. Integration is provided at no additional cost, and no proprietary hardware is required, simplifying deployment and maintenance. For clinics preferring a stand-alone approach, DxScript can be implemented and ready for use within 24 hours—a testament to its user-centric design and commitment to minimizing onboarding hurdles. DxScript’s hallmark features extend beyond basic ePrescribing. The system includes advanced decision support, powered by AI and machine learning algorithms, to alert providers in real time to potential drug-to-drug, drug-to-allergy, and drug-to-food contraindications at the point of care. This ensures safer prescribing and reduces the likelihood of harmful medication errors. If an alert is triggered, the platform can suggest suitable drug alternatives, guiding physicians toward optimal therapy decisions. The software offers integrated Prescription Drug Monitoring Program (PDMP) access within the provider’s workflow—a critical functionality for supporting regulatory compliance around schedule drug prescriptions. PDMP is seamlessly embedded, granting automatic connectivity to state-specific databases and enabling prescribers to check a patient’s controlled substance history efficiently.

DxScript is engineered as both a stand-alone and fully integrated cloud-based application, compatible with over 100 EMR, EHR, and practice management systems without requiring proprietary hardware or additional costs. Its broad compatibility—delivered through standardized APIs (HL7, FHIR, CDA, SOAP)—means that healthcare organizations can deploy DxScript rapidly across diverse IT environments and scale as needed without workflow disruption. Most competitor platforms impose costly or technically restrictive integrations, while DxScript offers this as a core value. A distinguishing technical advantage for DxScript is the use of artificial intelligence and machine learning for real-time drug interaction, allergy, and contraindication alerts directly within the prescribing workflow. It automatically suggests safer or more cost-effective drug alternatives when risks are identified. Its Fill Status Alerts (FSA) proactively notify physicians if patients have not picked up prescriptions within five days, directly addressing medication non-adherence. This level of smart alerting and workflow automation reduces prescription abandonment and enhances both patient outcomes and physician productivity.

• Small Businesses (1-99)
• Mid Market (100-500)
• Enterprise (500+)